Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct;16(5):1667-1677.
doi: 10.1007/s41999-025-01259-z. Epub 2025 Jul 21.

Factors associated with motor manifestations in older adults with Alzheimer's dementia: a cross-sectional analysis

Affiliations

Factors associated with motor manifestations in older adults with Alzheimer's dementia: a cross-sectional analysis

Ioannis Liampas et al. Eur Geriatr Med. 2025 Oct.

Abstract

Purpose: Motor signs are frequently observed over the clinical course of Alzheimer's disease (AD). We explored the potential clinical associations of motor manifestations in AD.

Methods: Our sample consisted of older adults (≥ 60 years) with AD from NACC. Individuals with Parkinson's disease or other Parkinsonian syndrome or under anti-parkinsonian agents were excluded. UPDRS III was used to assess motor signs in nine domains: hypophonia; masked facies; resting tremor; action/postural tremor; rigidity; bradykinesia; impaired chair rise; impaired posture/gait; postural instability. A global motor variable assessed the presence of at least one motor sign. Binary logistic models were estimated for the global (primary) and individual motor domain variables (secondary outcomes).

Results: A total of 4771 older, predominantly female, well-educated participants were analysed: 3556 without (75.4 ± 7.6 years, 45.6% males) and 1215 with motor manifestations (79.4 ± 7.8 years, 44.4% males). The most influential risk factor for motor manifestations in AD was the Clinical Dementia Rating stage: stage one increased the odds of motor signs by ~ 44%, stage two by ~ 168% and stage three by ~ 437%. Each additional point on the Geriatric Depression Scale elevated the odds of motor manifestations by ~ 5%, whereas each additional point on the Mini-Mental State Examination decreased these odds by ~ 2.5%. Cerebrovascular disease (by ~ 44%), diabetes mellitus (by ~ 25%), traumatic brain injury (by ~ 30%), alcohol abuse (by ~ 33%), anxiolytics (by ~ 36%), antidepressants (by ~ 31%), antipsychotics (by ~ 48%) and β-blockers (by ~ 33%) elevated the odds of motor manifestations. Angiotensin II receptor blockers decreased the odds of motor manifestations (by ~ 33%).

Conclusion: Disease progression constitutes the most crucial clinical risk factor for motor manifestations in AD.

Keywords: Angiotensin II receptor blockers; CDR; Cognitive performance; Depression; Neuropsychiatric symptoms; β-blockers.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing Interests: None. Ethical approval: All procedures were overseen by Institutional Review Boards at each Alzheimer’s Disease Research Centers and were in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments. Informed consent: All participants provided informed consent prior to their participation.

Figures

Fig. 1
Fig. 1
Participant flowchart
Fig. 2
Fig. 2
Determinants of motor manifestations in Alzheimer's disease dementia
Fig. 3
Fig. 3
Determinants of motor manifestations in Alzheimer's disease dementia among individuals ≥80 years of age

References

    1. Andrade-Guerrero J, Martínez-Orozco H, Villegas-Rojas MM, Santiago-Balmaseda A, Delgado-Minjares KM, Pérez-Segura I et al (2024) Alzheimer’s disease: understanding motor impairments. Brain Sci 14:1054. 10.3390/brainsci14111054 - PMC - PubMed
    1. Siokas V, Liampas I, Lyketsos CG, Dardiotis E (2022) Association between motor signs and cognitive performance in cognitively unimpaired older adults: a cross-sectional study using the NACC database. Brain Sci 12:1365. 10.3390/brainsci12101365 - PMC - PubMed
    1. Schuh RA, Jackson KC, Schlappal AE, Spangenburg EE, Ward CW, Park JH et al (2014) Mitochondrial oxygen consumption deficits in skeletal muscle isolated from an Alzheimer’s disease-relevant murine model. BMC Neurosci 15:24. 10.1186/1471-2202-15-24 - PMC - PubMed
    1. Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, Dubois B, Sarazin M, Brandt J et al (2004) Motor signs during the course of Alzheimer disease. Neurology 63:975–982. 10.1212/01.wnl.0000138440.39918.0c - PMC - PubMed
    1. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA (2006) Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol 63:1763–1769. 10.1001/archneur.63.12.1763 - PubMed

Grants and funding

LinkOut - more resources